logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 [see all tables in this series...]

Part (viii) Percentage distribution of all inpatient clients by primary drug for each age group

Substance<1515-1920-2425-2930-3435-3940-4445+Age knownAge not known
Opioids0.821.146.958.956.450.444.623.51241822
Cocaine0.82.53.54.45.863.92.111010
Stimulants4.219.71610.79.710.311.710.3333645
Hypnotics and sedatives564.57.311.916.922.146.33529559
Hallucinogens2.50.80.30.20.20.20.10711
Volatile substances24.47.82.31.410.90.60.754414
Cannabis 30.331.917.89.976.35.83.532022
Other substances 31.910.28.77.189.111.313.6244631
Total119243360546370416829751894263426647674

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, GR, CY, LU, HU, AT, RO, SK, FI, SE, UK, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-105 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI — outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008